Skip to main content

Table 2 Software for designing, simulating, and conducting dose-finding trials using rule-based designs and the CRM

From: How to design a dose-finding study using the continual reassessment method

Name

Host/Institution

Software/Stand-alone

Free/Commercial

Rule-based/Model-based

Description

bcrm [88]

CRAN

R

Free

Both

Design, run, and simulate trials using the CRM and 3 + 3 design

dfcrm [18]

CRAN

R

Free

Model-based

Design, run, and simulate trials using the CRM and Time-to-event CRM

crmPack [89]

CRAN

R

Free

Both

Design, run, and simulate trials using the CRM (includes other model-based designs, joint toxicity-efficacy modelling)

crm [90]

IDEAS (RePEc)

Stata

Free

Model-based

Run a single trial using the CRM

MoDEsT [91]

Lancaster University

Stand-alone (online)

Free

Model-based

Design, run, and simulate trials using the CRM

Bayesian CRM for phase I trials [92]

University of Virginia

Stand-alone (online)

Free

Model-based

Design, run, and simulate trials using the CRM

AplusB [93]

MRC Biostatistics Unit, University of Cambridge

Stand-alone (online)

Free

Rule-based

Compute exact operating characteristics for 3 + 3 and other rule-based designs

Center for Quantitative Sciences Calculator [94]

Vanderbilt University

Stand-alone (online)

Free

Both

Simulate trials using the CRM (uses bcrm [88] and dfcrm [18]) and other designs (rule-based/model-based)

CRMSimulator [95]

MD Anderson Cancer Center, University of Texas

Stand-alone

Free

Model-based

Simulate trials using the CRM

FACTS [96]

Berry Consultants

Stand-alone

Commercial

Both

Design program for phase I trials using the CRM, plus fixed and adaptive designs for phase II trials

ADDPLAN [97]

ICON PLC

Stand-alone

Commercial

Both

Design, simulate, and analyse trials using the CRM (includes methods for dose-response modelling)

  1. Abbreviations: CRAN Comprehensive R Archive Network, CRM Continual Reassessment Method, FACTS Fixed and Adaptive Clinical Trial Simulator, MoDEsT Model-based Dose-Escalation Trials, RePEc Research Papers in Economics